If you are talking about the commercialised product then the company has said that that is likely to begin being used in the latter part of next calendar year. There is a reasonable chance that life then will be not so lockdowned as now. They have said that COVID has stuffed their stage 7 study around (but in fairness it was supposed to have been running during 2019 so the COVID excuse is not that strong) but they have recently said that they should be good to go with the EU CE Mark approval and possibly with the TGA process by the end of this calendar year.
If you are talking about the commercialised product then the...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.93M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 141372 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 4216 | 1 |
View Market Depth
| Last trade - 10.06am 06/08/2024 (20 minute delay) ? |
| RHY (ASX) Chart |
Day chart unavailable